摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-acetyl-7-trifluoroacetamido-8-nitro-1,2,3,4-tetrahydroisoquinoline | 724783-85-1

中文名称
——
中文别名
——
英文名称
N-acetyl-7-trifluoroacetamido-8-nitro-1,2,3,4-tetrahydroisoquinoline
英文别名
N-(2-acetyl-8-nitro-3,4-dihydro-1H-isoquinolin-7-yl)-2,2,2-trifluoroacetamide
N-acetyl-7-trifluoroacetamido-8-nitro-1,2,3,4-tetrahydroisoquinoline化学式
CAS
724783-85-1
化学式
C13H12F3N3O4
mdl
——
分子量
331.251
InChiKey
QDOSDSNBKFDOLX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    95.2
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-acetyl-7-trifluoroacetamido-6-nitro-1,2,3,4-tetrahydroisoquinolineN-acetyl-7-trifluoroacetamido-8-nitro-1,2,3,4-tetrahydroisoquinoline盐酸 作用下, 以 甲醇 为溶剂, 反应 0.83h, 以30%的产率得到N-乙酰基-7-氨基-6-硝基-1,2,3,4-四氢异喹啉
    参考文献:
    名称:
    [EN] NOVEL NUCLEOSIDE TRANSPORT INHIBITORS
    [FR] NOUVEAUX INHIBITEURS DU TRANSPORT DES NUCLEOSIDES
    摘要:
    公开号:
    WO2004060902A3
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Flow Cytometric Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Conformationally Constrained Analogues of Nitrobenzylmercaptopurine Riboside (NBMPR) Designed for Probing Its Conformation When Bound to the es Nucleoside Transporter
    摘要:
    Novel regioisomers of conformationally constrained analogues of the potent es nucleoside transporter ligand, nitrobenzylmercaptopurine riboside (NBMPR), designed for probing its bound (bioactive) conformation, were synthesized and evaluated as es transporter ligands by flow cytometry. Purine 6-position 5, 6, 7, or 8-nitro-1,2,3,4-tetrahydroisoquinolylpurine ribosides, in which the nitrobenzyl moiety in NBMPR has been locked into the nitro-1,2,3,4-tetrahydroisoquinoline system, were synthesized by reaction of the appropriate nitro-1,2,3,4-tetrahydroisoquinoline with 6-chloropurine riboside. Flow cytometry was performed using 5-(SAENTA)X8-fluorescein as the competitive ligand. A high degree of variation in the es transporter binding capacity of the target compounds was observed, with the K-i values ranging from 0.45 nM for the most tightly bound compound (4) to 300 nM for the least tightly bound compound (5). The Ki of NBMPR was 0.70 nM, a little higher than that of compound 4. Compound 4 is the isomer that has the nitro group in the best orientation at the es transporter binding site compared to the other three compounds, 2, 3, and 5.
    DOI:
    10.1021/jm020405p
点击查看最新优质反应信息

文献信息

  • Novel Nucleoside Transport Inhibitors
    申请人:Buolamwini Kwesi John
    公开号:US20070293444A1
    公开(公告)日:2007-12-20
    Compounds or compositions that are inhibitors and/or ligands of nucleoside transporters; and methods of treating cancer, heart disease and stroke, as well as AIDS and other infectious diseases
    抑制核苷酸转运体的化合物或组合物;以及治疗癌症、心脏病和中风,以及艾滋病和其他传染病的方法。
  • US7582616B2
    申请人:——
    公开号:US7582616B2
    公开(公告)日:2009-09-01
  • Synthesis and Flow Cytometric Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Conformationally Constrained Analogues of Nitrobenzylmercaptopurine Riboside (NBMPR) Designed for Probing Its Conformation When Bound to the <i>e</i><i>s</i> Nucleoside Transporter
    作者:Zhengxiang Zhu、John Furr、John K. Buolamwini
    DOI:10.1021/jm020405p
    日期:2003.2.1
    Novel regioisomers of conformationally constrained analogues of the potent es nucleoside transporter ligand, nitrobenzylmercaptopurine riboside (NBMPR), designed for probing its bound (bioactive) conformation, were synthesized and evaluated as es transporter ligands by flow cytometry. Purine 6-position 5, 6, 7, or 8-nitro-1,2,3,4-tetrahydroisoquinolylpurine ribosides, in which the nitrobenzyl moiety in NBMPR has been locked into the nitro-1,2,3,4-tetrahydroisoquinoline system, were synthesized by reaction of the appropriate nitro-1,2,3,4-tetrahydroisoquinoline with 6-chloropurine riboside. Flow cytometry was performed using 5-(SAENTA)X8-fluorescein as the competitive ligand. A high degree of variation in the es transporter binding capacity of the target compounds was observed, with the K-i values ranging from 0.45 nM for the most tightly bound compound (4) to 300 nM for the least tightly bound compound (5). The Ki of NBMPR was 0.70 nM, a little higher than that of compound 4. Compound 4 is the isomer that has the nitro group in the best orientation at the es transporter binding site compared to the other three compounds, 2, 3, and 5.
  • [EN] NOVEL NUCLEOSIDE TRANSPORT INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DU TRANSPORT DES NUCLEOSIDES
    申请人:BUOLAMWINI JOHN K
    公开号:WO2004060902A3
    公开(公告)日:2004-10-07
查看更多